What's New in Research Funding

Page last updated September 21, 2017.

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:
 

September 21, 2017

  • 2017 Oliver Smithies Lecture: Dr. Daniel J. Drucker, M.D. - “Gut Peptides as Therapeutic Targets: 100 Years and Just Getting Started”. Dr. Daniel Drucker is a professor of Medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and the Canada Research Chair in Regulatory Peptides and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin biology. A pioneer in diabetes treatment, Dr. Drucker has provided important insights leading to the development of new drugs for the treatment of Type 2 diabetes and short bowel syndrome. Currently, his laboratory focuses on understanding the family of hormones produced in the pancreas, gastrointestinal tract and brain. His current work may help patients with Crohn’s disease and other intestinal disorders. Dr. Drucker has received numerous national and international awards in recognition of his research accomplishments and was named an Officer of the Order of Canada in 2015. LECTURE POSTER.
    Date: Tuesday, October 3, 2017 3pm-4pm 
    Venue: 7 Hart House Circle - Music Room 

    Please RSVP to medicine.research@utoronto.ca
     
  • Physicians' Services Inc. Foundation (PSI):
    • PSI Graham Farquharson Knowledge Translation Fellowship 2018. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Please review the guidelines for eligibility and further information. Application form here. Electronic applications should be submitted to cindy.faber@utoronto.caFaculty of Medicine internal ieadline: Monday, October 23, 2017 at 9am.
    • PSI Research Trainee Fellowship 2018. The primary aim of this fellowship is to provide highly qualified Medical Doctors (M.D.) with clinically applicable research training opportunities and support. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Please review the guidelines for eligibility and further information. Application form here. Electronic applications should be submitted to cindy.faber@utoronto.ca. Faculty of Medicine internal deadline: Wednesday, October 25, 2017 at 9am.
       
  • Prostate Cancer Innovation Fund. The University of Toronto (UofT) has partnered with Astellas Pharma to create the Prostate Cancer Innovation Fund with the purpose of supporting and advancing prostate cancer research. Under the direction and supervision of an interdisciplinary UofT review committee, overseen by the Chair of the Division of Urology, the Fund will provide 2 grants in the amount of $50,000. Grants are open to faculty members in the Faculty of Medicine and across UofT’s affiliated hospitals and research institutes, with academic appointment to the following Departments: Surgery; Medicine; Laboratory Medicine & Pathobiology; Radiation Oncology; or Medical Imaging. View the Request for Applications and the Terms of Reference. Deadline for proposals: December 1, 2017.
     
  • Alpha Phi Foundation: 2018 Heart to Heart Grant.  This program aims to provide $100,000 in grant funding to support innovative research studies and educational programs that aim to inform health care professionals and women about the causes, prevention and treatment of heart disease. Deadline for applications: November 1, 2017.
     
  • Epilepsy Canada: The Jay & Aiden Barker Breakthrough Grant in Clinical & Basic Sciences 2017. Epilepsy Canada (EC) is requesting research proposals from established researchers to conduct investigations that explore the basic mechanisms of epileptic seizures. Epilepsy Canada has set aside up to $200,000 to be awarded to a single winner, or apportioned to multiple award winners, by December 31, 2017. They are looking for a widespread assortment of submissions. In particular, they're interested in submissions that are high risk in nature that if successful would have near term applicability in the treatment of epilepsy and hopefully lead to finding a cure.  Deadline for LOIs: October 1, 2017 at 8pm EDT; Full application deadline: November 1, 2017 at 8pm EDT.
     
  • Bill and Melinda Gates Foundation (BMGF): Grand Challenges Exploration.
  • DEBRA International: Innovative Research Call. This Grant funding scheme is a new opportunity for researchers within and outside the Epidermolysis Bullosa (EB) field to explore innovative ideas in EB that could ultimately accelerate the field of EB research. DEBRA supports world-class research worldwide. Upper amount: €120,000 EUR fo up to two years. Deadline for applications: October 3, 2017.
     
  • The Gilbert Family Foundation: Gene-Targeting Strategies for Neurofibromatosis Type 1. Proposals will be accepted for Team Science Awards defined as collaborative research amongst investigators with experience in gene-targeting strategies in or outside the field of NF1. GFF expects to provide at least $7 million USD over three years among multidisciplinary teams of two or more established Principal Investigators (PIs), providing at least $1.2 million USD per team. Deadline for LOIs: September 29, 2017 at 5pm ET. Invited proposal deadline: December 8, 2017.
     
  • Tourette Association of America (TSA): Research Grant and Fellowship Program. TSA requests research grant proposals from researchers in basic and clinical studies on all aspects of Tourette syndrome. All applications relevant to Tourette Syndrome will be considered. Applications that will enable TSA to establish the prevalence of TS and tic disorders in adults are strongly encouraged. Post-Doctoral Fellowships are funded at up to $50,000 USD for one year. Research Grant Awards are funded at up to $75,000 USD for one year or up to $150,000 USD for two years. Deadline for preliminary proposals: November 1, 2017.
     
  • Oxalosis and Hyperoxaluria Foundation (OHF): Research Grants. The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a cure for Primary Hyperoxaluria and related Hyperoxaluria conditions. $200,000 USD for up to two years. Indirect costs must be included in the maximum funding amount. Deadline for applications: November 1, 2017.
     
  • Food Allergy Research and Education (FARE): FARE Investigator in Food Allergy Awards (Mid-career to established in field). FARE is the world's largest private source of funding for food allergy research. FARE sponsors basic and clinical research at major medical centers worldwide. FARE invests in studies to find a cure and to better diagnose and treat food allergy symptoms and complications, including anaphylaxis and chronic diseases of the skin and gastrointestinal tract. All proposed research projects must be relevant to food allergy. Deadlines for concept paper/proposals varies.

 

September 12, 2017

  • PSI Graham Farquharson Knowledge Translation Fellowship. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Please review the guidelines for eligibility and further information. Application form here. Electronic applications should be submitted to cindy.faber@utoronto.caFaculty of Medicine Internal Deadline: Monday, October 23, 2017 at 9am.
     
  • Weston Brain Institute: Rapid Response Canada 2018 (Parkinson’s & Related Diseases – Round 1). The Rapid Response: Canada program provides seed funding for high-risk, high-reward, translational research projects on neurodegenerative diseases of aging. View the RFA. The funding amount is a maximum of $200,000 over up to 18 months per project. Note that the Institute has changed its definitions for tools and therapeutics.  Please visit here for more details. 
    Program Webinar - Parkinson’s & Related Diseases: October 10, 2017 at 1:00pm EDT. Register here.
    Deadline for LOIs: December 4, 2017 at 2:00pm EDT
     
  • National Sanitarium Association - NSA Innovative Research Program 2017. NSA grants under the Innovative Research Program are intended to provide well-established investigators with start-up (venture) funding for innovative, emerging, and important new areas of research in the broad field of pulmonary science and medicine. Established fields of research that are supported by traditional funding agencies are not eligible for consideration. It is expected that during the course of an NSA grant (of up to five years), the investigators will capture grants from traditional funding agencies, so that the project becomes self-sustaining by the end of the NSA funding period. SA grants may provide funding of up to $1 million over a period of up to five years. The funds can be used to recruit investigators to an established research group and to provide them with initial salary support; for research equipment and operating expenses; and for the support of graduate students and research fellows.  Link to guidelines and the application formDeadline for Applications: October 15, 2017.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)
    • The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
    • Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
    • Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
    • Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
    • The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
    • Pregnancy in Women with Disabilities (R03) and (R01)
    • NIBIB Exploratory/Developmental Research Grant Program (R21)
    • Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
    • Biology of Lung, and Head and Neck Preneoplasias (R01) and (R21)
    • NIH Blueprint for Neuroscience Research: Dynamic Neuroimmune Interactions in the Transition from Normal CNS Function to Disorders (R01)
    • Partnerships for Countermeasures Against Select Pathogens (R01) 
    • BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01) 
    • Secondary Analyses of Existing Alcohol Research Data (R01) and (R03)
    • Detection of HIV for Self-Testing (R61/R33)
    • BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01)
    • Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) and (R01)
    • Research on Transgender Health (R21) and (R01)

September 6, 2017
 

  • University of Toronto - Connaught New Researcher Awards. The Connaught Committee is pleased to announce the New Researcher Award competition.  Up to $1,000,000 will be awarded in the 2017-18 academic year to help new tenure stream faculty members establish competitive research programs.  A majority of the available funds will be allocated to awards of up to $10,000; and the remaining funds will be allocated to top-up a limited number of these awards to a maximum of $35,000.  Top-up funding will be provided to the highest ranked proposals that also identify a specific need for the additional funding.  No matching required. Questions should be addressed to connaught.secretariat@utoronto.ca or 416-978-7118. Deadline for Applications: December 1, 2017.
     
  • CIHR Strategic Training for Advanced Genetic Epidemiology (STAGE): Call for Applications 2017. 
    Visit here for eligibility details, and here for application details.
    Questions should be directed to Patricia Nguyen, Stage Program Coordinator at stage.dlsph@utoronto.ca.
    Application Deadline: Friday, October 27, 2017.
     
  • CIHR Doctoral Research Awards. For this competition, applications will be accepted in all areas of health research, but according to CIHR's Priority Announcement, there are additional sources of funding for highly rated applications in the following specific research areas: HIV/AIDS, Infection and Immunity, Refugee Training Awards, and Research in First Nations, Métis &/or Inuit Health. Amount: $35,000 per year ($30,000 trainee stipend + $5,000 research allowance) for 3 years. Internal deadline for UofT applicants: September 26, 2017 (MRA needed from applicant's supervisor). CIHR deadline for applications in ResearchNet: October 3, 2017. Non UofT applicants, please contact the Research Office of the institution through which you are applying.
    UofT Research Office webpage for the Doctoral Research Award, with internal requirements and FAQs. 
    MRA handout for UofT applicants.
     
  • CIHR Peer Review Process: Opportunity for Early Investigators - Call for expressions of Interest. CIHR is pleased to announce the launch of an Observer program for early career investigators (ECIs) to participate as an observer in the peer review process of the Project Grant: Fall 2017 competition. Selected ECIs will be invited to observe one of the 53 committee meetings taking place in Ottawa as part of the review process for the Project Grant competition. There will be one ECI per committee.  As observers, the ECIs will not participate in review discussions. The face-to-face meetings will be held in Ottawa between November 15 and December 14, 2017. Exact dates will be confirmed with each selected ECI once they are assigned to a committee. CIHR will cover the travel costs for the ECI to attend the committee meeting. Deadline for Expressions of Interest: September 19, 2017.
     
  • CIHR Catalyst Grant: Sex as a Variable in Biomedical Research. This funding opportunity aims to encourage biomedical scientists to include sex as a variable in their research questions and experimental designs. In support of this aim, the Institute of Gender and Health (IGH) has developed a free online course that examines how sex can be integrated into biomedical research at every stage of the research project. Applications must propose to introduce a new research question that incorporates sex as a biological variable into a new or established research project. View the call for relevant research areas. Deadline for Applications: October 30, 2017.
     
  • Stem Cell Network (SCN): New Funding CompetitionSCN is pleased to launch a new funding competition to support high-quality translational research and clinical trials in stem cell and regenerative medicine research. SCN anticipates awarding approximately $4 million through this peer-reviewed competition. The funding will support novel research that will ultimately realize both health and economic benefits for Canadians. Call for Proposals for all funding programs will be open until October 16, 2017. All proposals will be peer reviewed and results of the competitions will be announced in early 2018. Contact: Cate Murray, Executive Director, SCN catemurray@stemcellnetwork.ca, Tel: 613-979-6174
     
  • NSERC Webinars. Note that NSERC has limited space in their webinars. Should you not be able to join, you can always connect through the teleconference and follow along with the presentation which will be available on NSERC's website. Considering the high attendance at NSERC's webinars, NSERC staff may not have time to respond to individual questions during the session. Questions should be directed to NSERC's support team: RESGRANT@NSERC-CRSNG.GC.CA. Conference # 1 877-413-4790, Conference ID 7462843
    • How to complete and submit a Discovery Grant application (English: Wednesday, September 27 from 1pm - 3pm ET; and Thursday, September 21, 2017 from 1pm - 3pm ET)
    • How to submit a Research Tools and Instruments application (English: Thursday, September 14, 2017 from 1pm - 3pm ET)
       
  • SSHRC Partnership suite of programs - Partnership Engage, Partnership Development & Partnership LOI:  INORMATION SESSION. Research Services will hold an information workshop for the upcoming Partnership Engage Grants, Partnership Development Grants and Partnership LOI Grants competitions. Professor Ito Peng, a Selection Committee member, will discuss the adjudication process and the elements of a strong proposal. There will also be advice on proposal preparation from our editorial team. RSVP by noon September 15 to sheila.vanlandeghem@utoronto.ca.
    Date: Tuesday, September 19, 2017 from 9:30am - 11:30am
    Location: Governing  Council Room in Simcoe Hall, 27 King's College Circle
     
  • POGO (Pediatric Oncology Group of Ontario): 2017-2018 Seed and Fellowship Grant Competition.
    • Seed Funding Grant: Grants of up to $15,000 to facilitate or support feasibility studies, the development of preliminary data to enable applications to other granting agencies, or self-contained studies. Registration Deadline: October 6, 2017; Submission Deadline: November 17, 2017.
    • Fellowship Training: To enhance the PRU’s mandate, goals, and research agenda, POGO has established two research fellowships (PhD/Post Doctoral Fellowship and Clinician Scholar Award). This award includes a yearly salary of $55,000 (Clinician Scholar), $45,000 (Post-Doctoral), or $30,000 (PhD) and the ability to apply for $5,000 in project-specific one-time operating support. Registration Deadline: October 6, 2017; Submission Deadline: November 17, 2017. 
       
  • Oxalosis and Hyperoxaluria Foundation (OHF): Research Grant Program. The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a cure for Primary Hyperoxaluria and related Hyperoxaluria conditions. OHF will award up to $200,000 total cost per project after a competitive process to select the most meritorious projects. Application Deadline: November 1, 2017.
     
  • American Foundation for Suicide Prevention (AFSP): Standard Research Grants. Standard Research Grants of up to $50,000 USD per year for a two-year period are awarded to investigators at any academic rank. AFSP suicide research grants program priority areas for 2017-19 are Pain and suicide, and Opioids and suicide. AFSP research grants and fellowships are awarded to individuals affiliated with not-for-profit institutions or organizations in the U.S. and abroad. Deadline for Applications: November 15, 2017.
     
  • Cancer Research Institute (CRI): Clinic and Laboratory Integration Program (CLIP) Grants. CRI offers its Clinic and Laboratory Integration Program (CLIP) Grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The program supports basic, pre-clinical, and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. Candidates for a CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Upper amount: $100,000 USD per year for two years. Deadline for Letters of Intent: November 1, 2017.
     

August 15, 2017
 

  • The Connaught Committee is pleased to announce the 2017-18 Connaught Innovation Award competition.  The Committee has approved $750,000 for awards of up to $100,000 to accelerate the development of promising technology and promote commercialization and/or knowledge transfer. For each project, a Notice of Intent (NOI) must be submitted to the Connaught Secretariat by September 11, 2017 in order to facilitate the selection of reviewers. Full applications are due by October 16, 2017. Projects must be based on inventions or research discoveries that are already disclosed to the University as of August 28, 2017.Full program details and application materials can be found on the Connaught Innovation Award page
     
  • CIHR College of Reviewers: Become a CIHR College of Reviewers member. Enrolment to the College began in June 2017. To build the College membership base, enrolment is proceeding in a phased-in approach, beginning with current and recently active CIHR reviewers in major funding competitions. Initial enrolment efforts will focus on individuals who fully meet the Membership Selection Criteria. The College Chairs will oversee the enrolment process while continuing to shape the direction of the College. The College will work closely with research institutions to bolster participation and recognition. For more information about becoming a College member, please contact  college@cihr-irsc.gc.ca.
     
  • CIHR and AstraZeneca (AZ): Early Career Investigator to support research in the area of locally advanced or metastatic bladder cancer. ICR is pleased to announce a Recent Partnership with AstraZeneca (AZ) to develop the independence of New Investigators in initiating and conducting research in the area of metastatic bladder cancer. The This partnership will provide funding for one award. Maximum amount per award is $115,000 for up to 3 years. Important note: Information on the addition of the metastatic bladder cancer pool will be updated in ResearchNet shortly. Deadline for full applications: September 6, 2017.
     
  • Burroughs Wellcome Fund: Upcoming Grant Opportunities.
    • Physician-Scientist Institutional Program. This is a five-month planning grant (up to $30,000) to focus on developing a full proposal for submission to the Burroughs Wellcome Fund to create programs to increase the number M.D.’s who enter careers in research. Deadline for Pre-Proposals: September 28, 2017. 
    • Career Awards for Medical Scientists. The Career Awards for Medical Scientists provide $700,000 over five years for physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service. This award addresses the on-going problem of increasing the number of physician scientists and will help facilitate the transition to a career in research. Deadline for Applications: October 3, 2017.
       
  • The Kidney Foundation of Canada: 2018 Biomedical Research Grant Competition. Grants are available for one, two or three years, commencing July 1, for up to $50,000 per year. Questions about the program should be directed to elisabeth.fowler@kidney.ca. Registration Deadline: September 1, 2017; Full Application Deadline: October 1, 2017.
     
  • Grand Challenges Canada: Saving Brains - Round 6. Grand Challenges Canada is seeking bold ideas for products, services and implementation models that protect and nurture early brain development in a sustainable manner. Areas of particular interest include innovations designed for use in humanitarian contexts and fragile settings, innovations that provide support to adolescent parents, and innovations with demonstrated scale and strong paths to sustainability that have not yet measured impact on child development. Grand Challenges Canada will fund proposals for up to $250,000 CAD for 24 months. Internal Deadline for UofT applicants: October 6, 2017; Sponsor Deadline: October 11, 2017.
     
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): (Edmond J. Safra Core Programs for PD Research)
    • Target Advancement Program: Target Advancement Awards support one-year grants up to $100,000 total costs inclusive of both direct and indirect costs. Deadline for Preliminary Proposals: September 27, 2017.
    • Therapeutic Pipeline Program: Pre-clinical funding is $200,000-$400,000, appropriate to the stage of research. Clinical funding is commensurable with the stage and goals. Deadline for Preliminary Proposals: September 27, 2017.
       
  • Alzheimer's Association (ALZ): International Research Grant Program. The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. Each total award is limited to $150,000 USD (direct and indirect costs) for up to three years (minimum 2 years). Deadline for Letters of Intent: September 26, 2017. Full proposal invitations for accepted proposals in December 2017. Full proposal deadline: January 23, 2018.
     
  • Barth Syndrome Foundation Inc.: Research Grant Program. The Foundation and its international affiliates announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome. The Foundation is interested in providing "seed grant funding" to young investigators as well as attracting experienced investigators new to the field of Barth syndrome basic science or clinical research. There are two basic categories: IDEA grants for 1-2 years and DEVELOPMENT grants for 2-3 years with budgetary maximums of US $50,000 or $100,000, respectively. Deadline for Letters of Intent: September 7, 2017.

August 2, 2017

  • Banting & Best Diabetes Centre (BBDC): Funding Opportunities.
    • Sun Life Financial Pilot and Feasibility Grants 2018/2019. This program provides funding of up to $40,000 per application to enable eligible investigators to explore new initiatives in the area of biomedical research/basic sciences.  (This program is not intended to support activities in diabetes care delivery, evaluation of diabetes education programs, or practical issues in diabetes management.) Up to three awards will be made available for this competition. Deadline for applications November 14, 2017.
    • Sun Life Financial New Investigator Award for Diabetes Research 2018-2020, and Reuben & Helene Dennis Scholar in Diabetes Research 2018-2020. These awards are intended to support new clinician-scientists and basic scientists in the early stages of their careers. One Sun Life Financial New Investigator Award and one Reuben & Helene Dennis Scholar award will be made available for this competition.  The Sun Life Financial New Investigator Award provides funding of $40,000 per year for two years, and the Reuben & Helene Dennis Scholar award provides funding of $10,000 per year for two years. Funds may be used for diabetes research support and/or the salary of a clinician-scientist conducting diabetes research.  Deadline for applications: October 24, 2017.
       
  • CIHR Webinars on students' awards in health research. CIHR will be offering information sessions to students and university staff about CIHR award programs, which will include relevant CIHR policies, tips for applicants, guidelines on how to submit an application, and the opportunity to ask questions. The sessions will allow all participants to be connected and discussions will be supported with a view of a PowerPoint presentation. University department/faculties are encouraged to facilitate a location where groups of students can attend the session together; however, students may also register individually. Participants must have access to a computer with internet connection to access the session and view the PowerPoint presentation. Questions may be directed to CIHR via the webinar chat function. UofT applicants, please make note of UofT's internal requirements (i.e., the MRA) described in this handout.
  • CIHR Operating Grant: Secondary Data Analysis - Dynamic Cohorts. The purpose of this funding opportunity is to provide funding to support cross-jurisdictional research on high system users using the Dynamic Cohort to improve the evidence for policy making in Canada. A detailed overview of the cohort and descriptive statistics from 2011-2015 is available here. Relevant program and policy decision-makers must be included on the research team, and the research questions must be driven by the needs of policy makers to have evidence-informed decision making. Upper amount: $70,000 for up to one year. Deadline for Applications: October 3, 2017.
     
  • J.P. Bickell Foundation – Annual Medical Research Program Grants. Grants are made to assist biomedical scientists of various departments and faculties in Ontario universities, hospitals and scientific institutions concerned with medical research. New researchers, with new, innovative projects receive priority. These grants may be distributed among medical research institutions and universities in Ontario, but each institution may submit only one application from any medically oriented faculty. Among other things, the application must be accompanied by an Institutional letter of support. Grants are usually between $50,000 and $65,000 each. For University of Toronto applicants, please visit here for more. For all other applicants, please contact your institution's research office, as the application and guidelines are shared by the J.P. Bickell Foundation with institutional research offices. 
    UofT applicants only - Internal deadline: October 1, 2017; Sponsor Deadline: November 1, 2017.
     
  • Chan Zuckerberg Initiative - RFA: Pilot Projects for a Human Cell Atlas. Although the focus of the project is analysis of human data, we are interested in new ideas and will consider proposals that focus on data from human tissues, non-human animals, organoids, and cell lines. We encourage proposals from areas of machine learning entirely outside of computational biology, e.g. deep learning. Proposals will be evaluated based on the computational novelty and viability of the method, a commitment to collaboration, the intention to interoperate with existing efforts such as the Human Cell Atlas Data Coordination Platform, and a plan to ensure that software is sharable, portable, and reproducible. Proposed pilot projects should be one year in duration with a projected start date of no earlier than August 1, 2017. Deadline for applications: August 28, 2017.
     
  • Alpha-1 Foundation (A1F): In-Cycle Grant Opportunities: Pilot and Feasibility Grant. The objective of this grant is to provide funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to AAT Deficiency. Proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in AAT research or development of novel methods, and providing sufficient preliminary data to justify the Foundation's support. Upper amount: $75,000 USD for up to one year. Deadline for Letters of Intent: September 22, 2017.
     
  • Leukemia & Lymphoma Society (LLS): Specialized Center of Research Program. LLS's Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects. Upper amount: $1,000,000 USD per year for five years. LLS welcomes applications from both US citizens and non-citizens, as well as applicants who are performing research outside the U.S. Deadline for Letters of Intent: September 22, 2017.

  • BrightFocus Foundation: Alzheimer's Disease Research (ADR): Standard Awards. The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies. BrightFocus Foundation awards grants for basic, translational, and clinically oriented research on the causes of, or treatments for, age-related and degenerative diseases. The scientific plan should be well focused and able to stand alone. Upper amount: $300,000 USD payable over three years. Deadline for Applications: October 18, 2017.
     

  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) and (R03) and (R01)
    • Central Neural Mechanisms of Age-Related Hearing Loss (R01)
    • BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21)
    • Tobacco Regulatory Science (R01) and (R21)
    • Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
    • Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
    • Synthetic Biology for Engineering Applications (R01)
    • Discovery of cell-based Chemical Probes for Novel Brain Targets (R21) and (R01)
    • Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

 

July 20, 2017
 

  • CIHR Foundation Grant Update. The Acting President of the Canadian Institutes of Health Research, Dr. Roderick McInnes, has announced an update to its Foundation Grant program.  Of note the following changes have been made to the program effective with the 2017-18 competition:
    • The total funding envelope for the Foundation Grant program will be reduced from $200M to $125M, with the $75M reduction will be redirected to the Project Grant program.
    • Early career investigators (ECIs) will not be eligible to apply to the Foundation Grant program; starting with the 2017-18 competition, but CIHR will ensure that the success rate of ECIs is equalized in the Project Grant program.  Any ECIs who have already submitted a registration to the current 2017-18 competition will have their registrations withdrawn.
       
  • Ted Rogers Centre for Heart Research: Innovation Fund Strategic Grants - DEADLINE EXTENDED. The Ted Rogers Centre for Heart Research is now accepting submissions for its first-ever strategic grants, which provide funding of up to $1 million over 3 years for transformative research projects focused on discovery, development and implementation of next-generation approaches and therapies to address heart failure. Eligible projects must represent a bona fide collaboration with at least 2 of 3 of the Centre’s partners: The Hospital for Sick Children, University Health Network, University of Toronto (any partners worldwide may be co-applicants). Contact: Linda Donovan, Planning & Operations Manager, linda.donovan@tedrogersresearch.ca. Deadline for Letters of Intent has been extended to: July 28, 2017 at 5pm. 
     
  • The Terry Fox Research Institute/Terry Fox Foundation.
    • The Terry Fox New Investigator Awards support outstanding new researchers as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration with established research teams. Deadline for Applications: September 8th, 2017.
    • The Terry Fox New Frontiers Program Project Grants support multidisciplinary teams of excellence that contribute to well-defined research topics of relevance to cancer. Deadline for Letters of Intent: August 8, 2017.
       
  • Leukemia & Lymphoma Society (LLS): Translational Research Program. The Translational Research Program puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. Upper amount: $200,000 USD over 3 years. Grants are eligible for renewal. Deadline for Letters of Intent: September 29, 2017.
     
  • Vasculitis Foundation: Seed Funding. The purpose of this program is to provide seed grants to support pilot studies in researching: Etiology/Pathogenesis; Epidemiology, including genetics; Diagnosis, including identification of disease subtypes; and Treatment/Management, including therapeutics to treat vasculitis or prevent complications, biomarkers, and psychosocial outcomes. Upper amount: $50,000 USD per year for up to two years. This program funds research worldwide. Deadline for Applications: August 18, 2017.

  • Simons Foundation Autism Research Initiative (SFARI): SFARI Explorer Awards. Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder. Upper amount: $50,000 USD for one one year (non-renewable). Deadline for Applications: Continuous.
     

  • Frick Foundation for Research on ALS. The goal of the foundation is to provide research grants for the study of the understanding of the basic causes of amyotrophic lateral sclerosis (ALS). These awards are not directed to clinically related projects for patient care. There is no geographical limitation for the recipients of these grants. Upper amount: Fr100,000 CHF over two years. Deadline for Applications: September 30, 2017.
     

  • Mizutani Foundation for Glycoscience. The foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences. The Foundation distributes grants to qualified scientists regardless of their nationalities or ethnic origins. Upper amount: ¥7,000,000 JPY total for up to three years. Deadline for Applications: September 1, 2017.


     

July 11, 2017

  • CIHR Project Grant: Fall 2017 Competition Launch and Webinars. As announced on July 10 by Dr. Rod McInnes, Acting President, changes have been made as a first step to improving the Project Grant competition. Read the full message. To support this funding opportunity, CIHR will be holding a series of Question and Answer webinars on the Project Grant: Fall 2017 application. Webinars will start on Thursday, July 20 and will provide participants with a brief overview of recent changes and an opportunity to ask questions. For more information and to register, please visit the CIHR Webinars page. Please note that the guidelines in ResearchNet are for both the Fall 2017 and the Spring 2018 competitions.
    • Registration period: July 11 to August 15, 2017
    • Application period: August 16 to September 15, 2017 (funding start date: April 2018)
       
  • Ted Rogers Centre for Heart Research: Innovation Fund Strategic Grants. The Ted Rogers Centre for Heart Research is now accepting submissions for its first-ever strategic grants, which provide funding of up to $1 million over 3 years for transformative research projects focused on discovery, development and implementation of next-generation approaches and therapies to address heart failure. Eligible projects must represent a bona fide collaboration with at least 2 of 3 of the Centre’s partners: The Hospital for Sick Children, University Health Network, University of Toronto (any partners worldwide may be co-applicants). Contact: Linda Donovan, Planning & Operations Manager, linda.donovan@tedrogersresearch.ca. Deadline for Letters of Intent: July 21, 2017 at 5pm. 
     
  • Healthy Behaviour Data Challenge. The Healthy Behaviour Data Challenge is an international partnership between Canada (CIHR and the Public Health Agency of Canada) and United States partners (the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services). The objective of the Healthy Behaviour Data Challenge is to identify and use creative new types of data and data sources to enhance public health surveillance of physical activity, sedentary behaviour and sleep. The challenge is being coordinated by the MaRS Discovery District. Register by August 4, 2017 to participate.
     
  • CIHR New Investigator Awards in Circulatory and Respiratory Health - PRE-ANNOUNCEMENT. These awards will provide early-career investigators from a variety of research backgrounds the opportunity to initiate and conduct research in the area of circulatory and/or respiratory health by providing protected research time via a stable salary base and operating funds. The maximum amount per award is $115 000 for up to three years for a total of $345 000. 
     
  • Epilepsy Foundation: New Therapy - Commercialization Grants Program.  The mission of this program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Deadline for Letters of Intent: July 21, 2017.
     
  • Progeria Research Foundation: Research on Hutchinson-Gilford Progeria Syndrome (HGPS, or Progeria). PRF will consider proposals in all areas directly relevant to Progeria. Two priority areas are 1. Discovery of biological markers of disease in HGPS that can be assessed in human and/or mouse samples; 2. Discovery and/or testing of candidate treatment compounds in both cell based and mouse models of HGPS. Awards are given in 3 categories: Innovator Awards, Established Investigator Awards, and Specialty Awards (for smaller, more technology-driven projects). Deadline for Proposals: September 19, 2017.

 

June 28, 2017

 

  • CIHR: Enrolment to the CIHR College of Reviewers began in June 2017. By forming the College, CIHR aims to enhance the current peer review system by systematizing reviewer recruitment to identify and mobilize the appropriate expertise for the review of all funding applications. The quality and diversity of the scientific expertise in the College will directly impact the quality of the review process of all of our CIHR funding proposals.  We strongly encourage you to nominate a colleague, or self-nominate. Acting CIHR President Roderick McInnes expressed the importance of a robust College of Reviewers in his recent visit to Toronto at the June 12th open dialogue hosted by the University of Toronto. If you’re interested in nominating, or learning more about the College – please contact college@cihr-irsc.gc.ca
  • CIHR: SPOR & JDRF Canada: Innovative Clinical Trials (iCT) in type 1 diabetes. As part of SPOR, the (iCT) initiative aims to build capacity and increase the intensity of iCT research. This funding opportunity is focused on the type of innovative clinical trials that involve comparative effectiveness research and/or implementation science research. The maximum amount per grant is $750,000 per year for up to four years for a total of $3,000,000 per grant. Deadline for Letters of Intent: August 8, 2017.
     
  • CIHR: SPOR Innovative Clinical Trial (iCT) Multi-Year Grant (2017). As part of SPOR, the iCT initiative aims to build capacity and increase the intensity of iCT research. iCTs use designs that are alternative to traditional Randomized Controlled Trials (RCTs) with application in areas ranging from product development to health system improvement. CIHR will provide funding for iCTs that have a primary focus in the research areas of comparative effectiveness research; and/or implementation science research. The maximum amount per grant is $375,000 per year for up to four years for a total of $1,500,000. Deadline for Letters of Intent: September 12, 2017.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • HIV/AIDS and the Tumor Niche (R01)
    • Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01)
    • Alcohol-Induced Effects on Tissue Injury and Repair (R21) and (R01)
    • Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
    • Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)
    • Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
    • Imaging the Persistent HIV Reservoir (R01)
    • Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)
    • Cellular and Molecular Biology of Complex Brain Disorders (R01) and (R21)
    • Global Brain and Nervous System Disorders Research Across the Lifespan (R21)  and (R01)
    • Multidisciplinary Studies of HIV/AIDS and Aging (R21) and (R01)
    • HIV/HCV Co-Infections in Substance Abusers (R01)
  • Cerebral Palsy Alliance: Career Development Awards. These awards are available to Early Career and Emerging in Field and to Mid-Career to Established in Field. Projects that address the causes, prevention, early interventions and cure of cerebral palsy will be rated more favourably when reviewing the merit of applications. Upper Amount $250,000 AUD. Citizenship or residency is unrestricted. Deadline for Applications: August 31, 2017.
     
  • MedEvac Foundation International: Research and Education Grants. The foundation awards funds to support the development of research and education in air medical and critical care ground transport. Studies that promote collaboration at the national or international level to complete the study or those that propose a critical review or meta-analysis of available evidence or salient work in a priority area are preferred. Deadline for Applications: July 28, 2017.
     
  • The Hope Foundation: SWOG/HOPE Foundation Impact Award. SWOG's mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. The SWOG/Hope Foundation Impact Award is a funding program that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. Upper amount $250,000 USD for up to two years. Deadline for Submissions: September 1, 2017.
     
  • Scleroderma Foundation: Established Investigator Grant. The Foundation seeks applications from promising individuals both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. Applicants may request up to $75,000 per year for up to two years. Deadline for Applications: September 15, 2017. 

 

Back to Top